SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SMS Pharmaceuticals has informed the stock exchanges that the trading window for its shares will remain closed from April 1, 2026, until 48 hours after the announcement of its financial results for the fourth quarter and full year ending March 31, 2026. This closure applies to all designated persons and their immediate relatives, as required under SEBI's Insider Trading Regulations and the company's own code of conduct. The board meeting date to approve the Q4 and annual results has not yet been announced and will be communicated later.
This is a routine regulatory compliance filing and does not directly affect shareholders. However, the upcoming financial results — expected to be declared within days of the window reopening — could be a key catalyst for the stock. Investors should watch for the board meeting announcement in the coming weeks.